Remote Temperature Monitoring of Patients At Risk for Developing Fever

Launched by AION BIOSYSTEMS · Dec 22, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how remote temperature monitoring can help cancer patients who are at risk of developing a fever after chemotherapy. The researchers want to find out if using a thermometer that continuously monitors body temperature can reduce the number of days patients need to spend in the hospital. They will also look at how much it might cost for patients to participate and how many medical billing codes are associated with this type of monitoring.

To take part in the study, participants need to be at least 18 years old, have a smartphone (either an iPhone or Android), and be willing to use a special app to track their temperature. They will wear a thermometer that sends alerts to their phone if their temperature goes too high. Participants will need to respond to these alerts and take their temperature as directed. The trial is currently recruiting patients, so if you or someone you know might be eligible and interested, this could be an important opportunity to help improve care for others in similar situations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subject is at risk of a fever post discharge.
• • Subject is ≥ 18 years or older.
• • Subject has an iOS or Android phone, or is able to operate an AION provided smartphone device.
• • Subject is willing to install the TempShield app on his/her phone.
• • Subject is willing to allow AION to send text reminders to take temperature or complete surveys.
• • Subject is willing to take an oral temperature as directed by their care plan.
• • Subject is willing to configure the phone to ensure these notifications are delivered, even when phone is in a "no notification" mode.
• • Subject or subject caretaker is able and willing to complete subject surveys.
• • Subject is willing and able to provide written informed consent in English.
• • Subject is willing and able to comply with all program procedures, requirements, assessments, visits, and complete questionnaires.
• • English speakers
• Exclusion Criteria:
• • Unable to provide informed consent
• • Subjects with a history of Medical Adhesive-Related Skin Injury (MARSI)
• • Subjects with no available placement that avoids open wounds or traumatized skin (burns. Blisters. Etc.)
• • Non-English speakers: The mobile application is only currently available in English. Future development will include other languages.
• • Subjects receiving prophylactics that could induce fever.
• • Subjects with a silicon allergy
• • Subject does not have iOS or Android phone, and is unable to operate an AION provided smartphone device.
• • Subjects who are not willing to take an oral temperature per their care plan.